In 1991, CB Research and Development was founded in a 2,000-square-foot facility to synthesize specialized chemical compounds for drug-makers. There were three employees. That same year, Incyte was founded in Palo Alto, California, to focus ...
Incyte Corporation has announced that the U.S. Food and Drug Administration (FDA) has approved Jakafi® (ruxolitinib) for the treatment of steroid-refractory acute GVHD in adult and pediatric patients 12 years and older. Jakafi is the ...
Reid Huber, executive vice president and chief scientific officer at Incyte, has a simple formula for how the company can keep ahead in a drug therapy environment that is moving more rapidly every year. “Speed, ...
Incyte Corporation today reported a $12 million net loss for the fourth quarter, compared to net income of $34 million for the same period in 2016. That’s a per-share loss of 6 cents for the ...
Incyte Corporation, one of the region’s largest pharmaceutical companies, today reported fourth-quarter and year-end financial gains for 2016. The company attributes the success, in part, to the growth of a few key products and the ...
WILMINGTON — Incyte Corporation, based in Wilmington, has announced the first patient has been treated in the REACH-1 pivotal Phase 2 trial evaluating its ruxolitinib drug, trademarked Jakafi. The drug was used in combination with ...
Produce Rx: Improving Access to Healthy Foods in Our Community - America enjoys one of the most abundant food supplies in the world, and in fact the United States is one of the world’s largest food exporters. And 
Achieving Success Along the Customer Journey - Ever since there’s been the practice of marketing communications, there’s been a concept inseparable from it: the customer journey. If you underst
The role of the private sector in the mentoring movement - It is always encouraged and appreciated when local businesses volunteer with nonprofits. The manpower and resources businesses are able to provide all
